BlackRock Institutional Trust’s Repros Therapeutics Inc. RPRX Stock Holding History

BlackRock Institutional Trust’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$925K	Buy	700,608 +25,760	+4%	+$44.8K	﹤0.01%	3309
2016 Q3	$1.41M	Hold	674,848	–	–	﹤0.01%	3178
2016 Q2	$1.09M	Buy	674,848 +133,237	+25%	+$256K	﹤0.01%	3280
2016 Q1	$525K	Hold	541,611	–	–	﹤0.01%	3451
2015 Q4	$655K	Hold	541,611	–	–	﹤0.01%	3442
2015 Q3	$4.02M	Sell	541,611 -97,995	-15%	-$749K	﹤0.01%	2818
2015 Q2	$4.57M	Sell	639,606 -211,926	-25%	-$1.65M	﹤0.01%	2802
2015 Q1	$7.32M	Buy	851,532 +1,561	+0.2%	+$14K	﹤0.01%	2574
2014 Q4	$8.47M	Buy	849,971 +13,817	+2%	+$118K	﹤0.01%	2456
2014 Q3	$8.28M	Buy	836,154 +34,159	+4%	+$506K	﹤0.01%	2445
2014 Q2	$13.9M	Buy	801,995 +3,803	+0.5%	+$62K	﹤0.01%	2213
2014 Q1	$14.2M	Buy	798,192 +84,138	+12%	+$1.63M	﹤0.01%	2199
2013 Q4	$13.1M	Buy	714,054 +3,597	+0.5%	+$67.9K	﹤0.01%	2235
2013 Q3	$19M	Buy	710,457 +187,531	+36%	+$4.02M	﹤0.01%	1891
2013 Q2	$9.65M	Buy	+522,926	New	+$9.24M	﹤0.01%	2342

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's RPRX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Repros Therapeutics Inc. (RPRX) stake by 3.8% in Q4 2016, buying an estimated $44.8K and bringing the position to 700,608 shares worth $925K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

BlackRock Institutional Trust first reported a position in RPRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $19M in Q3 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

BlackRock Institutional Trust held 700,608 shares of Repros Therapeutics Inc. worth $925K as of Q4 2016.
BlackRock Institutional Trust bought 25,760 Repros Therapeutics Inc. shares in Q4 2016, an estimated $44.8K.
Repros Therapeutics Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3309 holding.
BlackRock Institutional Trust first reported a position in Repros Therapeutics Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Repros Therapeutics Inc. position peaked at $19M in Q3 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.